By Ivana Sekularac BELGRADE (Reuters) -Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on ...
Serbia’s parliament descended into chaos on Tuesday as opposition lawmakers threw smoke grenades and tear gas inside the ...
1d
Hosted on MSNTenecteplase No Longer Off-Label as Stroke LyticNotably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...
Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...
A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...
20h
Woman&Home on MSNThis quick daily habit may reduce the risk of stroke and other heart conditions, a new study revealsWhen we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...
Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.
Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...
Research predicts stroke deaths may rise 50% globally by 2050, with younger people increasingly affected. Learn effective ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results